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Abstract: This study investigates the effects of 2-phenyl-1-benzopyran-4-one (flavone) on 
DENV-2 infectivity in Vero cells. Virus adsorption and attachment and intracellular virus 
replication were investigated using a foci forming unit assay (FFUA) and quantitative  
RT-PCR, respectively. Addition of flavone (100 μg/mL) significantly increased the number 
of DENV-2 foci by 35.66% ± 1.52 and 49.66% ± 2.51 when added during and after virus 
adsorption to the Vero cells, respectively. The average foci size after 4 days of infection 
increased by 33% ± 2.11 and 89% ± 2.13. The DENV-2 specific RNA copy number in the 
flavone-treated infected cells increased by 6.41- and 23.1-fold when compared to the  
mock-treated infected cells. Flavone (100 μg/mL) did not promote or inhibit Vero cell 
proliferation. The CC50 value of flavone against Vero cells was 446 µg/mL. These results 
suggest that flavone might enhance dengue virus replication by acting antagonistically 
towards flavonoids known to inhibit dengue virus replication.  
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1. Introduction  
Dengue virus (DENV) is a mosquito-borne virus belonging to the Flaviviridae family. There are 
four genotypes of dengue viruses and all four can cause dengue fever and its more severe forms 
dengue hemorrhagic fever and dengue shock syndrome [1]. Dengue causes significant health and 
economic burden to many tropical countries. Increasing urbanization, population growth and 
population mobility has contributed to further expansion of dengue-affected zones beyond the tropical 
and subtropical regions. The dengue quandary is further compounded by the lack of vaccines and 
antiviral drugs for effective prevention and control of the disease. Hence, there remains a need to 
intensify research to identify and develop potential antiviral drugs and vaccines for dengue. 
Phytochemicals remain the focus of many in vitro studies seeking compounds specific against 
dengue [2–4]. Among the important phytochemicals, flavonoids, which are polyphenolic compounds, 
have attracted great interest from the scientific community because of their diverse biological 
properties such as anticancer, antioxidant, and antimicrobial (including antiviral) activities [5–10]. 
Several studies on the effects of various bioflavonoids on dengue virus replication efficiency have been 
reported [11,12]. Flavonoids such as baicalein, apigenin, and fisetin have been shown to exert antiviral 
effects on hepatitis B, influenza viruses and dengue virus [11–15]. There are also reports of inhibition 
of the virus replication cycle by flavones, a subgroup of flavonoids that include compounds such as 
wogonin, apigenin and luteolin [9,14,15]. These compounds share a common 2-phenylchromen-4-one 
(2-phenyl-1-benzopyran-4-one) backbone. To date, there have been no reports on the effects of flavone 
itself on dengue virus replication. In the present study, we investigate the effects of the flavone 
backbone on DENV-2 replication. 
2. Results and Discussion  
2.1. Cytotoxicity of Flavone against Vero Cells 
African green monkey kidney cells (Vero) were treated with flavone for 4 days. The four day 
treatment duration was also the length of time used for evaluation of its activity on dengue virus 
replication. The cytotoxicity effects of flavone on Vero cells were determined using a MTT assay 
performed as previously described [16]. The CC50 value of flavones was 446 µg/mL when added 
directly to the cells. It was determined from this assay that 100 μg/mL flavone exerted no significant 
effects on cell viability and this concentration was used for all the subsequent studies. There was no 
observed cytotoxicity for cells treated with 1% DMSO, the solvent used to initially dissolve flavone.  
2.2. Evaluation of the Effects of Flavone on DENV-2 Replication  
The effects of flavone on adsorption and attachment of DENV-2 to Vero cells were determined by 
measuring the foci size and determining the number of viral foci formed on day 4 post-infection (PI) 
(Figure 1). In the presence of 100 µg/mL of flavone; added during virus adsorption and continuously 
after virus adsorption, the size of the viral foci on average increased by 33% ± 2.11 and 89% ± 2.13, 
respectively (Figure 2a).  
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Figure 1. The effects of flavone on DENV-2 foci formation in Vero cells. Infected cells 
were treated with 100 µg/mL of flavone (a) or mock-treatment medium (b) during virus 
adsorption and attachment. Virus foci were detected after 4 days of incubation using 
dengue hyperimmune sera. Enlarged viral foci diameter was obvious in the flavone-treated 
cells (arrows). 
 (a) 
 (b) 
The number of DENV-2 foci in Vero cells treated with 100 µg/mL of flavone at the time of virus 
adsorption and continuously after adsorption increased by 35.66% ± 1.52 and 49.66% ± 2.51, 
respectively, compared to the non-treated infected cells (Figure 3a). DENV-2 RNA copy number for 
cells treated with 100 µg/mL of flavone at the time of virus adsorption or after the infection was 6.41 
and 23.1 times higher than the copy number of viral RNA from cells infected in the absence of 
flavone, respectively (Figures 2b and 3b). These results suggest that DENV-2 infectivity was enhanced 
in cells treated with flavone, perhaps resulting in increased number of cells bearing progeny virus  
after a single round of infection. The increase in the size and number of foci was corroborated by  
the increased viral RNA copy number, suggesting possible enhancement of intracellular DENV-2 
replication. A number of previous studies have identified antiviral activities against some DNA or 
RNA viruses in various flavonoids as well as flavones such as baicalein [1,7,9–13].  
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Figure 2. The effects of flavone on DENV-2 infection of Vero cells. Cells were treated 
with flavone during virus adsorption and the number of foci formed at 4 days post-infection 
was determined using the foci forming unit assay (a) and the respective DENV-2 specific 
RNA copy number was quantified using qRT-PCR (b). All experiments were performed in 
triplicates. Data (n = 3) were plotted using Graph Pad Prism Version 5. 
(a) (b) 
Figure 3. The effects of flavone on intracellular DENV-2 replication in Vero cells. Cells 
were treated with flavone continuously after virus adsorption and the number of foci 
formed was determined using the foci forming unit assay (a) and the respective DENV-2 
RNA copy number was quantified using qRT-PCR (b). All experiments were performed in 
triplicates. Data (n = 3) were plotted using Graph Pad Prism Version 5. 
(a) (b) 
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There are, however, no published reports on the enhancement of virus replication by flavones. 
Drugs such as the pentavalent antimony compound sodium stibogluconate, arsenic trioxide and 
carbonyl cyanide m-chlorophenylhydrazone, on the other hand, have been shown to enhance HIV-1 
replication [17,18]. The effects on replication enhancement of HIV-1 is suggested to involve 
intracellular signaling pathways such as the mitogen activated protein kinase/extracellular  
signal-related kinase signal-transduction pathways and the activation nuclear factor—B and activator 
protein 1, known to regulate viral transcription [17]. In the case of arsenic trioxide it was thought that 
the compound counteracted the reverse transcription block caused by human Ref1. The mechanisms of 
how flavone enhances dengue virus infection on the other hand, are unknown. Results from studies 
with HIV, however, highlighted a few possible mechanisms and these include probable antagonistic 
effects on viral replication suppression by interferon. It is also worth noting that while some flavonoids 
inhibit dengue virus replication [11,12], flavone, which shares a common backbone with those 
flavonoids, produced the opposite effects. These results strongly suggest the possible involvement of a 
common regulatory pathway or protein affecting dengue virus replication that is affected by these 
compounds, albeit antagonistically. Future studies will be needed to address this possibility.  
3. Experimental  
3.1. Chemicals 
Flavone was purchased from Sigma Chemical Company (Sigma, St. Louis, MO, USA). Stock 
flavone solution was prepared in dimethyl sulfoxide (DMSO) (40 mg/mL) and stored at −20 °C.  
For the study, the stock solution was serially diluted in serum free cell culture medium and sterile-filtered 
using syringe filter with 0.2 μm pore size. The highest final concentration of DMSO used to treat cells 
was at 0.5%. 
3.2. Cells and Virus 
Dengue virus type-2 (DENV-2) New Guinea C strain (NGC) was used for the study. Virus was 
propagated in C6/36 Aedes albopictus monolayer cells at 28 °C in the presence of 3% CO2 and 
harvested on day 7 PI. Virus stock was prepared and titrated as previously described [19] and stored at 
−80 °C until needed. African green monkey kidney cells (Vero) was used for the foci forming unit 
assay (FFUA). Cells were cultured in Eagle’s Minimum Essential Medium (EMEM) containing 10% 
fetal bovine serum (FBS, Gibco, NY, USA) at 37 °C in the presence of 5% CO2. For maintenance 
medium, serum concentration was reduced to 2%. 
3.3. Cytotoxicity Assay 
The cytotoxicity of flavone was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide MTT assay, as previously described [16]. Confluent Vero cell 
monolayers were treated in triplicate with increasing concentrations of flavone. The treated cells were 
incubated for 4 days at 37 °C. After 4 days, MTT solution (Promega, Madison, WI, USA) (15 µL) was 
added to all wells. The microplate was incubated at 37 °C for 4 h in a humidified 5% atmosphere. 
After the incubation period, solubilization/stop solution (100 µL) was added to the wells.  
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The absorbance values of the wells were measured at 570 nm using a 96-well plate reader (TECAN, 
Mannendorf, Switzerland).  
3.4. Evaluation of the Effect of Flavone on DENV-2 Replication  
The effects of flavone on DENV-2 adsorption and attachment to cells as well as its intracellular 
replication were determined by examining the changes in: (i) the average size of viral foci; (ii) number 
of viral foci formed and (iii) DENV-2 RNA copy number, as determined by quantitative RT-PCR.  
All experiments were performed in triplicate with different concentrations of flavone. Briefly,  
to determine the effects of flavone on virus adsorption, Vero cells monolayer was prepared in 24-well 
cell culture microplates and inoculated with 200 FFU of DENV-2 in the presence or absence of 
different concentrations of flavone. The microplates were incubated at 37 °C for 1 h for virus 
adsorption and attachment to the cells. The cells were then washed with sterile PBS twice and 
incubated at 37 °C for four days. 
To evaluate the effects of flavone on DENV-2 intracellular replication, confluent Vero cells 
monolayer in 24 wells cell culture microplates were infected with 200 FFU of DENV-2 and kept at  
37 °C for 1 h for virus adsorption and attachment. Cells were washed twice with sterile PBS in order to 
remove the unadsorbed viruses. The cells were overlaid with 1.5% carboxymethylcellulose (CMC) 
containing cell-growth medium supplemented with 2% FBS containing different concentrations of 
flavone and the plates were incubated at 37 °C for 4 days. The size and number of viral foci were 
determined as described below. 
3.5. Foci Forming Unit Assay 
DENV-2 was titrated by foci forming assay as described previously [11]. Briefly, a Vero cell 
monolayer was prepared in 24 wells cell culture microplate. After attaining ~80% confluency, growth 
medium was removed and the cells were infected by DENV-2 in the presence or absence of flavone 
under the conditions described earlier. The microplate was incubated at 37 °C for 1 h for virus 
adsorption and attachment. Cells were then washed with sterile PBS twice and incubated at 37 °C  
for four days to allowviral foci to form. To visualize the DENV-2 foci, the cell culture medium was 
discarded and cells were washed gently three times with phosphate buffer saline (PBS). Then,  
10% paraformaldehyde was added to fix the cells for 30 min at room temperature (RT) followed by 
three times washing with PBS. NP40 1% (Sigma, St. Louis, MO, USA) was added to permeabilize the 
cell for 10 min at RT. Cells were washed three times with PBS and blocked with 3% skim milk 
solution prepared in PBS for 2 h at RT. After another three washings with PBS, the cells were 
incubated with dengue hyperimmune serum (produced in rabbit) diluted in 1:500 using 1% skim milk 
solution at 37 °C for 1 h. Cells were then washed three times with PBS and incubated with goat  
anti-rabbit IgG conjugated with horse-radish peroxidase (HRP) at final concentration of 1:250 in 1% 
skim milk solution (Sigma, St. Louis, MO, USA). Finally, 3'-diaminobenzidine (DAB) peroxidase 
substrate (Thermo Scientific Pierce, Rockford, IL, USA) was added to each well to stain the virus foci. 
Viral foci were counted under a SMZ 1000 stereomicroscope (Nikon, Tokyo, Japan) and expressed as  
Foci-Forming-Unit (FFU). The foci size was measured with NIS-Elements D Software v3.0 (Nikon).  
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3.6. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
The quantitative RT-PCR for determining DENV RNA copy number was performed as previously 
described [11,19]. Briefly, DENV-2 RNA was extracted from the DENV-2 infected cells and cell 
culture supernatant using the RNA extraction kit (Qiagen, Hilden, Germany). Quantitative RT-PCR 
was performed using SensiMix SYBR green mixture (Quantace, Watford, UK) in a total reaction 
volume of 20 µL consisting of ddH2O (7.4 µL), 2× SensiMix One-Step (10 µL), 50× SYBR Green 
solution (0.4 µL), RNase Inhibitor (10 units), 50 pmol each of forward (DNF) and reverse (D2R) 
primers, and the extracted DENV RNA (1 µL). 
All amplifications were performed in triplicates using the DNA Engine Opticon system  
(MJ Research/Bio-Rad, Hercules, CA, USA) with following amplification cycles: reverse transcription 
at 50 C for 30 min, initial denaturation at 95 C (10 min), followed by 45 cycles of 95 C for 15 s,  
59 C for 30 s and 72 C for 30 s. Melting curve analysis was performed at temperature from 60 C to 
98 C to verify the assay specificity (as previously described). For absolute quantitation of the viral 
RNA, a standard curve was established with a serially diluted RNA extracted from virus inoculum 
with known infectious virus titer. 
3.7. Statistical Analysis 
Statistical analysis was performed using Graph Pad Prism for Windows, version 5 (Graph Pad 
Software Inc., San Diego, CA, USA, 2005).  
4. Conclusions  
Results from this study suggest that the addition of flavone enhances DENV-2 replication in Vero 
cells. The mechanisms of how flavones influenced dengue virus replication is not known. However, 
the virus replication enhancement effects are most prominent when the infected cells were treated with 
flavone after virus adsorption and attachment. This implies that flavone acts intracellularly on the 
infected cells. Since a number of flavonoids have previously been shown to inhibit dengue virus 
replication, it is likely that flavone works through a similar molecule or pathway affected by the 
flavonoids. Further study will be needed to examine this possibility.  
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